Next Quarterly Earnings
Wednesday, November 18, 2026
CW 47
Pre-Market
In 83 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Oruka Therapeutics
Oruka Therapeutics is an innovative US-based biotechnology company specializing in the development of novel biologics for chronic skin diseases. Through precise research, the company optimizes therapeutic proteins to advance the treatment of immune-mediated conditions.
Frequently asked questions
When will Oruka Therapeutics report its next quarterly earnings?
Oruka Therapeutics is scheduled to report its next quarterly earnings on 11/18/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Oruka Therapeutics last report quarterly earnings?
Oruka Therapeutics last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -0.55 USD.
How does Oruka Therapeutics stock react to earnings?
Across its last 3 earnings reports, Oruka Therapeutics stock moved by ±10.9% on average the following day. The largest reaction was +25% on 03/12/2026; 3 of 3 reactions were positive.
How often has Oruka Therapeutics beaten expectations?
Oruka Therapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Oruka Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±10.9%
Avg. next-day move
+25%
Largest move (03/12/2026)
100%
Share of positive reactions
±13.1%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
+6.6%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Oruka Therapeutics
Country
🇺🇸
More Financial Information